PURPOSE: Childhood obesity is an increasing problem and is accompanied by metabolic disturbances. Recently, we have identified 14 serum metabolites by a metabolomics approach (FIA-MS/MS), which showed altered concentrations in obese children as compared to normal-weight children. Obese children demonstrated higher concentrations of two acylcarnitines and lower levels of three amino acids, six acyl-alkyl phosphatidylcholines, and three lysophosphatidylcholines. The aim of this study was to analyze whether these alterations normalize in weight loss. METHODS: We analyzed the changes of these 14 metabolites by the same metabolic kit as in our previous study in serum samples of 80 obese children with substantial weight loss (BMI-SDS reduction >0.5) and in 80 obese children with stable weight status all participating in a 1-year lifestyle intervention. RESULTS: In the children without weight change, no significant changes of metabolite concentrations could be observed. In children with substantial weight loss, glutamine, methionine, the lysophosphatidylcholines LPCaC18:1, LPCaC18:2, and LPCa20:4, as well as the acyl-alkyl phosphatidylcholine PCaeC36:2 increased significantly, while the acylcarnitines C12:1 and C16:1, proline, PCaeC34:1, PCaeC34:2, PCaeC34:3, PCaeC36:3, and PCaeC38:2 did not change significantly. CONCLUSIONS: The changes of glutamine, methionine, LPCaC18:1, LPCaC18:2, LPCa20:4, and PCaeC36:2 seem to be related to the changes of dieting or exercise habits in lifestyle intervention or to be a consequence of overweight since they normalized in weight loss. Further studies should substantiate our findings.
PURPOSE: Childhood obesity is an increasing problem and is accompanied by metabolic disturbances. Recently, we have identified 14 serum metabolites by a metabolomics approach (FIA-MS/MS), which showed altered concentrations in obesechildren as compared to normal-weight children. Obesechildren demonstrated higher concentrations of two acylcarnitines and lower levels of three amino acids, six acyl-alkyl phosphatidylcholines, and three lysophosphatidylcholines. The aim of this study was to analyze whether these alterations normalize in weight loss. METHODS: We analyzed the changes of these 14 metabolites by the same metabolic kit as in our previous study in serum samples of 80 obesechildren with substantial weight loss (BMI-SDS reduction >0.5) and in 80 obesechildren with stable weight status all participating in a 1-year lifestyle intervention. RESULTS: In the children without weight change, no significant changes of metabolite concentrations could be observed. In children with substantial weight loss, glutamine, methionine, the lysophosphatidylcholines LPCaC18:1, LPCaC18:2, and LPCa20:4, as well as the acyl-alkyl phosphatidylcholine PCaeC36:2 increased significantly, while the acylcarnitines C12:1 and C16:1, proline, PCaeC34:1, PCaeC34:2, PCaeC34:3, PCaeC36:3, and PCaeC38:2 did not change significantly. CONCLUSIONS: The changes of glutamine, methionine, LPCaC18:1, LPCaC18:2, LPCa20:4, and PCaeC36:2 seem to be related to the changes of dieting or exercise habits in lifestyle intervention or to be a consequence of overweight since they normalized in weight loss. Further studies should substantiate our findings.
Authors: Natalie J Serkova; Matthew Jackman; Jaimi L Brown; Tao Liu; Ryutaro Hirose; John P Roberts; Jacquelyn J Maher; Claus U Niemann Journal: J Hepatol Date: 2005-08-02 Impact factor: 25.083
Authors: Rui Wang-Sattler; Yao Yu; Kirstin Mittelstrass; Eva Lattka; Elisabeth Altmaier; Christian Gieger; Karl H Ladwig; Norbert Dahmen; Klaus M Weinberger; Pei Hao; Lei Liu; Yixue Li; H-Erich Wichmann; Jerzy Adamski; Karsten Suhre; Thomas Illig Journal: PLoS One Date: 2008-12-05 Impact factor: 3.240
Authors: M J Leal-Witt; M Ramon-Krauel; S Samino; M Llobet; D Cuadras; J C Jimenez-Chillaron; O Yanes; C Lerin Journal: Int J Obes (Lond) Date: 2017-08-17 Impact factor: 5.095
Authors: Christian Hellmuth; Olaf Uhl; Marie Standl; Hans Demmelmair; Joachim Heinrich; Berthold Koletzko; Elisabeth Thiering Journal: Obes Facts Date: 2017-04-05 Impact factor: 3.942
Authors: Kevin R Short; Jennifer Q Chadwick; April M Teague; Mary A Tullier; Lisa Wolbert; Charlotte Coleman; Kenneth C Copeland Journal: J Clin Endocrinol Metab Date: 2019-08-01 Impact factor: 5.958
Authors: Chelsea L Deschamps; Kimberly E Connors; Matthias S Klein; Virginia L Johnsen; Jane Shearer; Hans J Vogel; Joseph M Devaney; Heather Gordish-Dressman; Gina M Many; Whitney Barfield; Eric P Hoffman; William E Kraus; Dustin S Hittel Journal: PLoS One Date: 2015-06-24 Impact factor: 3.240
Authors: Simone Wahl; Susanne Vogt; Ferdinand Stückler; Jan Krumsiek; Jörg Bartel; Tim Kacprowski; Katharina Schramm; Maren Carstensen; Wolfgang Rathmann; Michael Roden; Carolin Jourdan; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Ute Nöthlings; Heiner Boeing; Fabian J Theis; Christa Meisinger; Melanie Waldenberger; Karsten Suhre; Georg Homuth; Christian Gieger; Gabi Kastenmüller; Thomas Illig; Jakob Linseisen; Annette Peters; Holger Prokisch; Christian Herder; Barbara Thorand; Harald Grallert Journal: BMC Med Date: 2015-03-09 Impact factor: 8.775
Authors: Richard D Semba; Michelle Shardell; Fayrouz A Sakr Ashour; Ruin Moaddel; Indi Trehan; Kenneth M Maleta; M Isabel Ordiz; Klaus Kraemer; Mohammed A Khadeer; Luigi Ferrucci; Mark J Manary Journal: EBioMedicine Date: 2016-02-19 Impact factor: 8.143